Wellington Shields & Co., LLC Amgen Inc Transaction History

Wellington Shields & Co., LLC

$303 Million
Q2 2024

A detailed history of Wellington Shields & Co., LLC transactions in Amgen Inc stock. As of the latest transaction made, Wellington Shields & Co., LLC holds 5,014 shares of AMGN stock, worth $1.62 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

5,014

Previous 5,414 7.39%

Holding current value

$1.62 Million

Previous $1.54 Million 1.75%

% of portfolio

0.52%

Previous 0.52%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$262.75 - $319.31 $105,100 - $127,724	-400 Reduced 7.39%	5,014 $1.57 Million
Q1 2024 May 23, 2024	BUY	$268.87 - $324.56 $161,322 - $194,736	600 Added 12.46%	5,414 $1.54 Million
Q1 2024 May 23, 2024	SELL	$268.87 - $324.56 $161,322 - $194,736	-600 Reduced 11.08%	4,814 $1.37 Million
Q1 2024 May 03, 2024	BUY	$268.87 - $324.56 $161,322 - $194,736	600 Added 12.46%	5,414 $1.54 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $306,110 - $380,044	1,400 Added 41.01%	4,814 $1.29 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $299,978 - $354,718	-1,400 Reduced 29.08%	3,414 $757,000
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $45,158 - $55,040	200 Added 4.33%	4,814 $1.16 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $673 - $759	3 Added 0.07%	4,614 $1.04 Million
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $692 - $770	3 Added 0.07%	4,611 $1.12 Million
Q1 2022 May 09, 2022	BUY	$219.27 - $242.57 $657 - $727	3 Added 0.07%	4,608 $1.11 Million
Q4 2021 Feb 15, 2022	BUY	$198.88 - $227.6 $152,938 - $175,024	769 Added 20.05%	4,605 $1.04 Million
Q3 2021 Nov 10, 2021	BUY	$212.27 - $248.7 $424 - $497	2 Added 0.05%	3,836 $816,000
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $34,336 - $38,093	-147 Reduced 3.69%	3,834 $934,000
Q1 2021 May 12, 2021	SELL	$221.91 - $258.6 $88,320 - $102,922	-398 Reduced 9.09%	3,981 $991,000
Q4 2020 Feb 09, 2021	BUY	$216.38 - $257.67 $29,427 - $35,043	136 Added 3.21%	4,379 $1.01 Million
Q3 2020 Nov 10, 2020	BUY	$234.65 - $260.95 $703 - $782	3 Added 0.07%	4,243 $1.08 Million
Q2 2020 Aug 05, 2020	SELL	$197.81 - $242.74 $26,110 - $32,041	-132 Reduced 3.02%	4,240 $1 Million
Q1 2020 May 07, 2020	BUY	$182.24 - $241.7 $364 - $483	2 Added 0.05%	4,372 $886,000
Q4 2019 Feb 11, 2020	BUY	$189.21 - $243.2 $826,847 - $1.06 Million	4,370 New	4,370 $1.05 Million
Q3 2019 Nov 05, 2019	SELL	$174.11 - $208.62 $733,873 - $879,333	-4,215 Closed	0 $0
Q2 2019 Aug 08, 2019	BUY	$166.7 - $195.41 $333 - $390	2 Added 0.05%	4,215 $777,000
Q1 2019 May 10, 2019	BUY	$180.87 - $203.88 $542 - $611	3 Added 0.07%	4,213 $800,000
Q4 2018 Feb 11, 2019	BUY	$178.4 - $208.25 $751,064 - $876,732	4,210 New	4,210 $820,000

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $173B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Shields & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Shields & Co., LLC with notifications on news.

Account

Wellington Shields & Co., LLC Amgen Inc Transaction History